Experienced clinical research professional joins Pearl Pathways

Pearl Pathways announces the hiring of Emily Baumann as a Clinical Research Analyst. Emily brings over four years of experience in global clinical trial project management and medical affairs to the Pearl Pathways Clinical Services team.

Emily Baumann Pearl Pathways reduced size clinical research analyst immuno-oncology

Emily Baumann, MHA

Emily’s expertise includes maintaining electronic data capture systems, writing project plans, and guiding study teams through the challenges of subject recruitment and retention. She possesses thorough experience in performing Phase I-III clinical trials in the therapeutic areas of immuno-oncology, hematology, neurology, gastroenterology, infectious diseases, and psychiatry.

Prior to joining Pearl Pathways, Emily served as a global clinical trials project specialist and medical monitoring associate for PRA Health Sciences. Emily completed her Master of Healthcare Administration (MHA) from The University of North Carolina at Chapel Hill and her Bachelor of Science (BS) in Biochemistry from The University of Wisconsin-Madison. Learn more about Emily Baumann by viewing her full biography.

Categories

Speaking with FDA

Questions to avoid and the right questions to ask.
READ MORE